Methotrexate – A new controlled comparative study, published in Annals of Medicine, examined effects of methotrexate on arterial blood pressure in patients with newly diagnosed rheumatoid arthritis (RA) who had not previously been treated with disease-modifying antirheumatic drugs (DMARDs).
A new experimental drug is showing promise in slowing the progression of disability in individuals with multiple sclerosis (MS), according to recent findings from a large clinical trial. The results have sparked optimism among patients, neurologists, and researchers alike, as current treatment options for MS often focus primarily on managing symptoms rather than significantly altering the course of the disease.
The U.S. Food and Drug Administration (FDA) has officially approved Tremfya (guselkumab) for the treatment of adults suffering from…
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), leading to neurological disability..
